🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2025-12-29
Trial ID
NCT07509086
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
The main goal of this trial is to evaluate the safety and tolerability of C...
Status
Recruiting
Location
Shanghai Mengchao Cancer Hospital
Start Date
2024-03-07
Trial ID
NCT06327997
Treatments Being Tested
This study is a single-center, open Phase I study, to observe the effective...
Status
Unknown
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2022-01-01
Trial ID
NCT05201118
Whole Brain Radiation Therapy (WBRT) has long been the mainstay of treatmen...
Status
Completed
Location
Gamma Knife Center Tilburg, Elisabeth-TweeSteden Hospital
Start Date
2016-02
Trial ID
NCT02953717
Treatments Being Tested
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Status
Recruiting
Location
Children's Hospital, Zhejiang University School of Medicine
Start Date
2025-12-01
Trial ID
NCT07305116
Treatments Being Tested
The purpose of this study is to evaluate the change in the expression of tr...
Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Start Date
2024-07-29
Trial ID
NCT06379217
This is a single-arm, phase II study aiming to evaluate the feasibility and...
Status
Unknown
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Start Date
2019-05-01
Trial ID
NCT04267549
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Multiple myeloma is a disease of B-lymphocytes producing malignant plasma c...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2000-08
Trial ID
NCT00171925
Treatments Being Tested